YZYingyao Zhou

Yingyao Zhou

*This is an algorithmically generated author record based on publicly available information.

Yingyao Zhou has a total of 22 co-authors. Here are the top co-authors by number of shared publications:

  • Bin Zhou

    Biologics Research Center, Novartis Biomedical Research , San Diego, CA 92121

    3 shared publications
  • Christopher Benner

    Department of Medicine, Division of Endocrinology & Metabolism, University of California, San Diego, La Jolla, California 92093, USA

    2 shared publications
  • Hao Chen

    Ray and Stephanie Lane Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA 15213, USA; Department of Computer Science, University of Illinois Chicago, Chicago, IL 60607, USA

    2 shared publications
  • Joel Hayashi

    Novartis Biomedical Research, San Diego, USA

    2 shared publications
  • John Joslin

    Novartis Biomedical Research, San Diego, USA

    2 shared publications
  • Lars Pache

    Center for Therapeutics Discovery, NCI Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA

    2 shared publications

Latest Publications

  • Open Access

    Afpdb: an efficient structure manipulation package for AI protein design

    by Yingyao Zhou, Jiayi Cox, Bin Zhou, Steven Zhu, Yang Zhong, Glen Spraggon

    The advent of AlphaFold and other protein Artificial Intelligence (AI) models has transformed protein design, necessitating efficient handling of large-scale data and complex workflows. Using existing programming packages that predate recent AI advancements often leads to inefficiencies in human coding and slow code execution. To address this gap, we developed the Afpdb package. Afpdb, built on AlphaFold’s NumPy architecture, offers a high-performance core. It uses RFDiffusion's contig syntax to streamline residue and atom selection, making coding simpler and more readable. Integrating PyMOL’s visualization capabilities, Afpdb allows automatic visual quality control. With over 180 methods commonly used in protein AI design, which are otherwise hard to find, Afpdb enhances productivity in structural biology by supporting the development of concise, high-performance code. Code and documentation are available on GitHub (https://github.com/data2code/afpdb) and PyPI (https://pypi.org/project/afpdb). An interactive tutorial is accessible through Google Colab. Supplementary data are available at Bioinformatics online.


  • Top Cited Papers
    Open Access

    Drug target prediction through deep learning functional representation of gene signatures

    by Hao Chen, Frederick J. King, Bin Zhou, Yu Wang, Carter J. Canedy, Joel Hayashi, Yang Zhong, Max W. Chang, Lars Pache, Julian L. Wong, et al.

    Many machine learning applications in bioinformatics currently rely on matching gene identities when analyzing input gene signatures and fail to take advantage of preexisting knowledge about gene functions. To further enable comparative analysis of OMICS datasets, including target deconvolution and mechanism of action studies, we develop an approach that represents gene signatures projected onto their biological functions, instead of their identities, similar to how the word2vec technique works in natural language processing. We develop the Functional Representation of Gene Signatures (FRoGS) approach by training a deep learning model and demonstrate that its application to the Broad Institute’s L1000 datasets results in more effective compound-target predictions than models based on gene identities alone. By integrating additional pharmacological activity data sources, FRoGS significantly increases the number of high-quality compound-target predictions relative to existing approaches, many of which are supported by in silico and/or experimental evidence. These results underscore the general utility of FRoGS in machine learning-based bioinformatics applications. Prediction networks pre-equipped with the knowledge of gene functions may help uncover new relationships among gene signatures acquired by large-scale OMICs studies on compounds, cell types, disease models, and patient cohorts.


  • Open Access

    Drug target prediction through deep learning functional representation of gene signatures

    by Yingyao Zhou, Hao Chen, Frederick King, Bin Zhou, Yu Wang, Carter Canedy, Joel Hayashi, Yong Zhong, Max Chang, Lars Pache, et al.

    Many machine learning applications in bioinformatics currently rely on gene identities extracted from input gene signatures, and fail to take advantage of preexisting knowledge about gene functions. We developed the Functional Representation of Gene Signatures (FRoGS) approach by training a deep learning model. FRoGS represents gene signatures projected onto their biological functions, instead of their identities, similar to how the word2vec technique works in natural language processing. We demonstrated that its application to L1000 datasets resulted in more effective compound-target predictions than models based on gene identities alone. Through further integration of additional pharmacological activity data sources, FRoGS significantly contributed to a large number of high-quality compound-target predictions, which were supported by in silico and/or experimental evidence. These results underscore the general utility of FRoGS in machine learning-based bioinformatics applications. Prediction networks pre-equipped with the knowledge of gene functions may help more readily uncover relationships among gene signatures acquired by large-scale OMICs studies on compounds, cell types, disease models, and patient cohorts.